The U.S. Food and Drug Administration (FDA) released a list of draft and final guidance topics that are a priority for the FDA Foods Program to complete within the next 12 months.
The U.S. Food and Drug Administration (FDA) has announced draft recommendations for industry on the naming of plant-based foods that are marketed and sold as alternatives to milk.
A group of non-government organizations have recently expressed concerns and raised questions about the U.S. Food and Drug Administration’s (FDA’s) vision for restructuring its Human Foods Program and Office of Regulatory Affairs (ORA).
The U.S. Food and Drug Administration (FDA) signed a domestic mutual reliance partnership agreement with the New York Department of Agriculture and Markets (NYSAGM), enhancing regulatory cooperation and collaboration between FDA and New York to ensure food safety.
The U.S. Food and Drug Administration’s (FDA’s) 2022 Food Code clarifies that food donations from retail food establishments are acceptable, given that proper food safety practices are followed.
New registration requirements for foreign food manufacturing facilities intending to export certain products to India have gone into effect, and the U.S. Food and Drug Administration (FDA) states that it has not yet received sufficient information about the scope of these requirements and the intended use of the registration information.
The U.S. Food and Drug Administration has announced a new, transformative vision for the agency’s Human Foods Program, as well as for the Office of Regulatory Affairs (ORA) to better support FDA as a whole.
Part of Food Safety Magazine’s series with the U.S. Food and Drug Administration (FDA), titled, “Evolution of a New Era: Advancing Strategies for Smarter Food Safety,” this episode of Food Safety Matters discusses improving traceability and transparency in the food supply chain through the implementation of the Final Food Traceability Rule, as mandated by Congress under the Food Safety Modernization Act (FSMA) Section 204. We are joined by Adam Friedlander, Policy Analyst in FDA’s Coordinated Outbreak Response and Evaluation (CORE) Network, and Joseph Lasprogata, Vice President of New Product Development at Samuels Seafood.
The U.S. Food and Drug Administration (FDA) has decided that cannabidiol (CBD) products will not be regulated as a food or supplement, rather, a new approach will be developed. The agency has also denied three consumer petitions requesting that FDA allow the marketing of CBD products as dietary supplements.
Frank Yiannas, Deputy Commissioner of Food Policy and Response at the U.S. Food and Drug Administration (FDA), has announced that he will be resigning from his position, effective February 24, 2023.
